By comparing natural immunity to Aspergillus fumigatus (AF) in vivo with the action of human or mouse phagocytes against AF in vitro, we delineated two sequential lines of defense against AF. The first line of defense was formed by macrophages and directed against spores. Macrophages prevented germination and killed spores in vitro and rapidly eradicated conidia in vivo, even in neutropenic and athymic mice. The second was the neutrophilic granulocyte (PMN), which protected against the hyphal form of AF. Human and mouse PMN killed mycelia in vitro. Normal, but not neutropenic mice, stopped hyphal growth, and eradicated mycelia. Either line of defense acting alone protected mice from high challenge doses. Natural immunity collapsed only when both the reticuloendothelial system and PMN were impaired. These findings are in keeping with the clinical observation that high doses of cortisone and neutropenia are the main risk factors for invasive aspergillosis. Cortisone inhibited the conidiacidal activity of mouse macrophages in vivo and of human or mouse mononuclear phagocytes in vitro. Cortisone damaged this first line of defense directly and not through the influence of T lymphocytes or other systems modifying macrophage function as shown in athymic mice and in vitro. In addition, daily high doses of cortisone in mice reduced the mobilization of PMN so that the second line of defense was also impaired. […] Find the latest version: A B S T R A C T By comparing natural immunity to Aspergillus fumigatus (AF) in vivo with the action of human or mouse phagocytes against AF in vitro, we delineated two sequential lines of defense against AF. The first line of defense was formed by macrophages and directed against spores. Macrophages prevented germination and killed spores in vitro and rapidly eradicated conidia in vivo, even in neutropenic and athymic mice. The second was the neutrophilic granulocyte (PMN), which protected against the hyphal form of AF. Human and mouse PMN killed mycelia in vitro. Normal, but not neutropenic mice, stopped hyphal growth, and eradicated mycelia. Either line of defense acting alone protected mice from high challenge doses. Natural immunity collapsed only when both the reticuloendothelial system and PMN were impaired. These findings are in keeping with the clinical observation that high doses of cortisone and neutropenia are the main risk factors for invasive aspergillosis. Cortisone inhibited the conidiacidal activity of mouse macrophages in vivo and of human or mouse mononuclear phagocytes in vitro. Cortisone damaged this first line of defense directly and not through the influence of T lymphocytes or other systems modifying macrophage function as shown in athymic mice and in vitro. In addition, daily high doses of cortisone in mice reduced the mobilization of PMN so that the second line of defense was also impaired. Thus, cortisone can break down natural resistance on its own. Myelosuppression rendered mice susceptible only when the first line of defense was overpowered by high chal-
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Cortisone lowers the normally high resistance of laboratory animals to invasive aspergillosis (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . For example, mice become extremely susceptible to aspergillosis after large doses of cortisone (13, 14, 23, 24) , but not after myelosuppression or neutropenia (14, 23) . Cortisone suppresses the accumulation of phagocytes at inflammatory sites, reduces bactericidal and candidacidal activity of monocytes, and impairs expression of cell-mediated immunity (25) (26) (27) . Although none of these actions of cortisone that might affect aspergillosis have been studied systematically, the interesting observation was made that spores of Aspergillus flavus germinated faster in alveolar macrophages of cortisone-treated mice (22, 28) .
In order to clarify the mechanisms of action of cortisone and to identify the role of myeiosuppression and neutropenia in lowering resistance to aspergillus infection, we have conducted experiments in a mouse model of invasive aspergillosis. Our findings, which also include observations made during direct comparisons in vitro of human and mouse phagocytes, allow us to delineate two lines of cellular defense that must be overcome by AF in order to establish disseminated infection.
METHODS

Organism
A strain of Aspergillus fumigatus (AF) isolated from the sputum of a patient at the University Hospital of San Diego was used for all experiments. Conidia were scraped with a wire loop from 4-to 6-d cultures on Sabouraud dextrose agar (SDA) plates supplemented with 100 ,g/ml of streptomycin and 100 U/ml penicillin G at 370C. Conidia were washed three times in 0.9% saline, clumps were disrupted with a Teflon pestle and a Tri-R Stir-R homogenizer (Tri-R Instruments, Inc., Rockville Center, N. Y.), and the suspension filtered through a 12-ml plastic syringe packed with cotton gauze. This procedure gave suspensions of 100% conidia (no mycelia) with > 95% single conidia.
Preincubated conidia. In some experiments conidia were preincubated in broth as follows: 5 X 107 filtered single conidia in a volume of 1-5 ml of 0.15 M saline were added to a 500-ml Erlenmeyer flask containing 200 ml of trypticase soy broth (TSB) supplemented with penicillin-streptomycin (PS) and incubated overnight at room temperature without shaking. After the conidia were collected by centrifugation at 800 g for 15 min, the pellet was washed three times in saline, resuspended, and dispersed into single conidia as described for plate cultures. Phase contrast microscopy showed that preincubated conidia were about four times larger in diameter but still round in form and free of germ tubes. (34, 35 Assay for killing of mycelia by PMN Tube assay. From suspensions of 120-250 CFU/ml of preincubated conidia in RPMI with 10% FCS and PS, aliquots of 100 gl were dispensed to 15 X 150-mm flat bottom glass tubes and incubated at 37°C until mycelial growth was seen by phase contrast microscopy (4-6 h). All tubes were centrifuged at 800 g for 15 min to ensure that mycelia adhered to the bottom of the tubes. 1 ml of a suspension 1-3 X 106 PMN in RPMI-1640 with 5% autologous, heat-inactivated serum, or medium and serum without PMN was added. In preliminary experiments it was determined that 3 X 10' cells were required to cover the bottom of the tubes from the center to the periphery. To establish contact between the leukocytes and the fungus, all tubes were centrifuged at 150 g for 5 min. In addition to the medium control, the effect of pelleting leucocytes onto mycelia was controlled with PMN that were killed by freezing and thawing (31) . After 12-h incubation, 2 ml of distilled water was added to all tubes and the mixture vortexed and incubated for 15 
Media
Statistical analysis
The median lethal dose (LD50) for mice challenged with conidia was calculated by the method of Reed and Muench (36) . The significance of differences observed in the LD50 experiments was computed by comparing the frequency of death with 2 X k contingency tables and by using the Bonferroni-X2 statistics tables for correction of multiple comparisons (37) . Differences of pooled data from several LD50 experiments were calculated at each dose level because group sizes were unequal from pooling. The results of the in vitro killing assay were also analyzed by 2 X k contingency tables with correction for multiple comparisons. Differences betweeen mean values were determined by t test.
RESULTS
Effects of immunosuppressive regimens on phagocytes. HN2 reduced drastically the total blood leukocyte and PMN counts (Fig. 1) To compare suppression of the cellular inflammatory response by CA and HN2, the peritoneal exudative response to heat-killed conidia was studied in normal, CA-, and HN2-treated mice (Fig. 2) . This experiment was repeated with live conidia, and similar results were obtained. When mice were treated in this experiment with CA from 2 d before stimulation with spores until cells were harvested, the total cellular response fell 93% below that of normal mice (P < 0.01). PMN fell 95% (P < 0.001), a suppression similar to that in HN2-treated mice. The number of resident peritoneal macrophages recovered after immunosuppression without stimulation with spores was 4.47±0.8 X 106 (mean±SD from six animals) in HN2-treated, and 3.95±0.83 X 106 in CAtreated mice compared with 5.4±1.6 X 106 in normal mice, demonstrating that the influx of new phagocytes rather than the pool of resident macrophages is affected by CA and HN2.
Comparative effect of HN2 and CA on susceptibility to intravenous conidia. One dose of CA 48 h before challenge reduced the LD50 of intravenous challenge by 1.7 log below normal mice (P < 0.01) in both simultaneous comparisons and four pooled experiments (Table I) . After continuous immunosuppression with 2.5 mg of CA for 6 d (beginning 2 d before challenge), the LD50 was 2.2 logs lower than that of animals treated only once with CA.
In contrast, neutropenia induced by HN2 lowered the LD50 by only 0.52 log (0.1 > P > 0.05, Table I ). Because HN2 and CA suppressed inflammation equally, we sought another explanation for the differences in susceptibility to aspergillosis. First, we examined the possibility that CA suppressed the T lymphocytes by challenging athymic mice with AF spores, but found them equally resistant. Moreover, athymic mice were as susceptible to immunosuppression with CA as CF1 mice (Table I) . To exclude the possibility that cortisone might lower resistance by blocking the early humoral immune response, we tested the susceptibility of mice with antibody titers of >1:100, which developed after active infection. They were as susceptible as their nonimmunized littermates (Table I) . Thus, CA lowers resistance even in the presence of humoral antibody.
We turned next to mononuclear phagocytes as the cortisone-susceptible defense system. We compared the susceptibility of normal, neutropenic, and CAtreated mice to preincubated spores because studies of Aspergillus flavus infections suggested that spores become resistant to macrophages after preincubation in broth (20) . Normal mice were only moderately more susceptible to preincubated spores than freshly collected spores (Table I: A log LD50:0.76, P < 0.01). The findings in CA-treated mice were similar (A log LDso:0.85, P < 0.01). Neutropenic mice, however, were much more susceptible to preincubated conidia than to fresh conidia (A log LD50:1.55, P <0.001). More (Fig. 3A) , kidneys (Fig. 3B) 24 and 48 h after challenge. Thereafter, CFU varied from >500/ml in infarcted livers to <10 ml in grossly normal livers (Fig.  3A) . The fungus always multiplied in the kidneys of CA-treated mice (Fig. 3B) , caused cortical lesions with a scant phagocytic response, and finally destroyed the medulla. In contrast, no lesions or fungal growth were seen in the kidneys of HN2-treated or normal mice. AF multiplied in the brains of five of nine CA-treated animals and in the lungs of one. Elimination of the fungus from the spleen was not impaired by CA, and the fungus did not multiply in this organ. Athymic mice and heterozygote littermates eliminated the fungus at the same rate from the liver (Fig.  4) , brain, spleen, and lung. In addition, the elimination pattern of spores from these organs by nu/nu-and nu/ +-BALB, mice was similar to that of CF1-mice, in spite of the higher challenge dose to athymic mice (2 X 105 vs. 6 X 104). This higher dose caused kidney infection with gross lesions in several nu/nu-and nu/+-mice. Between days 7 and 17 after challenge, >300 CFU/ ml of kidney homogenate were recovered from two of nine nu/nu-mice and three of nine nu/+-mice; the other mice eliminated the fungus from the kidneys by the pattern seen in CF1 mice with a lower challenge dose. Even with this protracted infection, there was no difference between athymic mice and phenotypically normal littermates.
DAYS AFTER CHALLENGE FIGURE 4 Clearance of resting conidia from the liver of nu/ nu-(0) and nu/+ (X) BALBC mice. Mean±SD of CFU recovered per milliliter of liver homogenate from three animals per group after injection of 2 X 105 conidia i.v. There was no significant difference in clearance between the two groups (all A CFU:NS).
Preincubation of spores in broth resulted in a marked change in organ distribution. 2 h after injection of preincubated conidia, more fungus was recovered from the lungs (25%), kidneys (5.5%), and brain (0.5%), and less from the liver (67%) and spleen (2%) than in experiments with resting spores. The altered distribution is attributed to the increased size of spores and might explain the increased susceptibility of normal, CA-treated and, in part, neutropenic mice. In addition to the altered distribution, the clearance of spores was reduced in myelosuppressed mice and the fungus was not eradicated as it was by normal mice. This difference was independent of the number of organisms reaching individual organs (Fig. 5A and  B) . Thus, myelosuppressed mice that eliminate resting spores at least as well as control mice could not mount an effective defense against preincubated spores. Clearance was delayed in all organs as early as 24 h after challenge and the fungus multiplied, especially in the kidneys and brain. In contrast, normal mice successfully controlled the infection in the kidneys and brain at the lower challenge dose. At the higher challenge dose (2 X 104 preincubated conidia), 75 times more CFU were recovered per milliliter of brain homogenate than in experiments with 6 X 104 resting spores. The higher challenge caused limited growth of the fungus in the brain of control animals but significantly less than in myelosuppressed mice (Fig. 6B ) and killed no normal animals by day 14, whereas myelosuppressed animals died within 6 d after challenge. Thus, normal mice controlled the infection even when challenged with 2 X 104 preincubated conidia.
Susceptibility of immunosuppressed mice to inhaled conidia. To find out if i.v. challenge was representative of natural infection, we exposed mice to conidia in an inhalation chamber. Normal mice were extremely resistant to inhaled conidia (Table II) and HN2-treated mice died only at high challenge doses. One dose of CA also had little effect on the lethality of inhaled fungi but continuous immunosuppression with 2.5 mg of CA for 6 consecutive d killed all animals exposed to spores, even at the lowest challenge dose of 2.5 X 105 CFU (Table II) . In contrast to normals, myelosuppressed mice given one dose of CA were vulnerable to challenge with a moderate dose of inhaled conidia. Thus, a challenge with <1.5 X 106 spores killed neither normal nor HN2-treated mice and only one mouse given a single dose of CA, but all mice treated with one dose of CA plus HN2 died. Mice treated with this combined regimen were as susceptible as those given daily injections of CA alone (Table II) .
Clearance of inhaled conidia. Normal CF1 mice eliminated conidia at highly consistent rates in three studies with different batches of mice (Fig. 6A) . Inhaled conidia were cleared efficiently by severely neu- (Fig. 6C) . sections from CA-treated mice showed progressively Unlike athymic and myelosuppressed mice, those more mycelia, invasion into blood vessels, and consetreated with CA exhibited impaired clearance of AF quent pulmonary infarction. Many spores appeared to (Fig. 6D) . By 24 h after inhalation, the clearance rate be ingested by mononuclear phagocytes, and transof conidia in CA-treated mice was significantly below formation of spores into mycelia was observed in phanormal. At 6. I mice. Cultures disclosed that invasive growth in the lungs was followed by dissemination of the fungus to the kidneys, brain, and liver in most CA-treated mice.
Interaction of human and murine macrophages with resting and preincubated spores of AF. Direct evidence for the importance of mononuclear phagocytes as the first line of defense against AF was obtained from studies on the interaction of macrophages with conidia. When spores were injected i.p., they were readily ingested by macrophages whether mice were immunosuppressed or not. When the peritoneal exudate was harvested 24 h after challenge, the spores were still predominantly in macrophages. In three different experiments, CA-treatment significantly impaired the ability of peritoneal macrophages to prevent transformation of spores into mycelia in vivo (Table III) . One dose of CA increased the germination rate at 24 h by two-to threefold and daily treatment by 8-to 10-fold. The faster germination was independent of the cellular composition of the peritoneal exudate that was similar in mice treated with HN2 or continuous CA. Because myelosuppressed mice retained the capacity to prevent germination, these experiments pointed to a functional disturbance in mononuclear phagocytes produced by CA.
Macrophages also slowed transformation of ingested spores into mycelia in vitro, but less efficiently than in vivo. Observations on germination rates were not possible beyond 24 h because progressive growth of escaping mycelia destroyed and overgrew the monolayer of phagocytes. Germination rates were highest between 15 and 21 h of co-culture but did not reach a definite plateau at 24 h, indicating that prevention of germination is not synonymous with killing of spores.
Cortisone inhibited the ability of macrophages to prevent germination of spores in vitro also. Germination rates increased significantly by 2.3-to 3.2-fold after resident or induced peritoneal mouse macrophages were exposed to cortisone in vitro or in vivo (Table IV) . Resident macrophages, whether exposed to CA or not, were less able to prevent germination; and co-cultures with resident cells had to be evaluated at 12 h because of fungal overgrowth. Direct stimulation of the fungi by cortisone was excluded because no cortisone was present in the culture medium when cells were infected, and germination was not enhanced when cortisone was added to conidia in medium alone (data not shown).
Human macrophages were comparably inhibited by cortisone (Table IV) . They also lost the ability to prevent germination of ingested spores after cortisone treatment. The mycelia sprouting from spores pierced the cells and spread rapidly extracellularly.
Macrophages could not prevent transformation of preincubated spores into hyphae. By 24 h after ingestion, very few nongerminated spores could be made out in macrophages, and the abundant mycelial forms of the fungus could no longer be counted individually so that an exact germination rate could not be determined. We solved this technical problem by showing that spores preincubated in tissue culture medium for 6 h before a 10-h period of phagocytosis transformed significantly faster than resting spores subjected to phagocytosis for 24 h. Mean transformation rates ±SD from two independent experiments were 33±3.8% for preincubated spores and 22±2.2% for resting spores (P < 0.005).
Because multiplication of escaping fungi made it impossible to test killing by demonstrating a reduction of CFU, we tried to determine if macrophages could sterilize small conidial inocula in microcultures. In five consecutive experiments, macrophages sterilized a significant number of wells to which small inocula of spores were added. Sterilization occurred in a dose range of 2 to 12 CFU per well and was dose dependent. No sterilization was detected when a dose of 22 CFU was added per well (Table V) . In contrast to the findings with resting spores, preincubated conidia were not killed in parallel microculture experiments with the same cell preparations as predicted by the inability of macrophages to prevent their germination (Table V) .
Killing of mycelia by human and murine PMN. In view of our in vivo evidence from the susceptibility and clearance studies that neutrophil granulocytes form the important defense line against AF after ger-
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A. Schaffner, H. Douglas, and A. Braude 26 CFU of conidia. There was no difference in killing between a crude leukocyte preparation (72% PMN; cells vs. media control P < 0.001) and purified PMN (96% PMN, cells vs. media control P < 0.001). Sterilization did not occur when centrifugation was omitted, the assay was performed in round-bottom tubes, or the leukocytes were killed by freezing or thawing. In a similar assay performed in micro-wells, we proved that it was PMN that killed hyphae by demonstrating that (a) PMN preparations of >99% purity sterilize microcultures, (b) the killing capacity of cell preparations with low PMN fractions is reduced, and (c) mononuclear cells (monocytes and lymphocytes) in excess of the number present in the PMN preparations cannot kill hyphae (Table VI) . We obtained similar results with mouse peritoneal leukocytes enriched either for PMN or mononuclear cells (Table VI) .
DISCUSSION
On the basis of these findings we delineate for the first time two distinct lines of defense against Aspergillus and show that both must be breached before the fungus can establish progressive infection. The following discussion recapitulates and synthesizes our findings in support of this premise and relates these experimental results to human aspergillosis.
Natural resistance directed against spores. These studies show that natural immunity to resting spores of AF is largely independent of PMN, T lymphocytes, and humoral immunity, and that mononuclear phagocytes form a very efficient defense system by rapidly killing the fungus in its conidial stage (Figs. 3, 4, 6 ).
In keeping with the reports that inhaled spores of Aspergillus flavus are seen predominantly in phagosomes of alveolar macrophages (22, 28) and that spores of AF are selectively phagocytized by mononuclear phagocytes in vitro (10), we found that spores of AF are readily ingested by macrophages in vitro and in vivo and preferentially removed by organs rich in reticuloendothelial phagocytes after i.v. injection. We demonstrated both in the peritoneal cavity and in vitro that macrophages of normal mice prevented germination of spores of AF, the prerequisite inhibitory step for killing the fungus in its conidial stage. Finally, we showed that peritoneal macrophages killed small inocula of resting spores in microcultures (Table V) . Cortisone inhibits killing of spores by macrophages. Cortisone significantly impaired the ability of macrophages to prevent germination of conidia in vitro (Table IV ) and in vivo (Table III) , and therefore (22, 28) that macrophages prevented germination of ingested conidia of Aspergillus flavus and that cortisone enhances intracellular germination, not only by duplicating this phenomenon with AF, but also by discovering three new properties of macrophages: (a) they kill ingested spores (Table V) , (b) they protect mice even after ablation of PMN (Tables I and II) , and (c) their function is impaired by a direct action of cortisone (Table IV) .
Natural resistance against mycelia. Although myelosuppression is believed to be the major risk factor for invasive aspergillosis in patients (1, 2) , it has only a minor deleterious effect on the natural resistance of laboratory animals and only with extremely high challenges of conidia (14, 23) . The potent defense against conidia provided by macrophages in our studies explains these discrepancies. The short term myelosuppression achievable in laboratory animals does not involve the pool of tissue macrophages that has a turnover rate of several months (38) and thus does not affect the function of the reticuloendothelial system.
We have shown that the roles of myelosuppression and neutropenia become evident only after conidia escape from the reticuloendothelial system and start mycelial growth. Overwhelming the macrophages by extremely high doses is not a realistic model of human disease, and it is not surprising that we could not demonstrate a significant difference in the susceptibility of neutropenic and normal mice when we used this tactic in the i.v. model (Table I) . However, as suggested for Aspergillus fiavus (20) , conidia of AF could be rendered resistant to macrophages by preincubation in broth. This simple maneuver revealed an impressive difference in the susceptibility of neutropenic and control mice to aspergillosis and unmasked the importance of the neutrophil granulocyte (Table I) .
When we tried to induce mycelial growth in normal animals by challenging them with a high dose of preincubated conidia, mycelia were scarce and surrounded by typical PMN-rich abscesses. In contrast, abundant mycelia invaded the tissues and encountered little or no PMN response in myelosuppressed or CA-treated animals. Cultures of the tissues showed that growth was limited and that fungi were eliminated by normal mice, whereas multiplication was unopposed in immunosuppressed animals (Fig. 5) . These findings, along with efficient killing of mycelia by PMN in vitro (Table VI) , establish granulocytes as the major defense against mycelia.
Relative importance of resistance against spores provided by macrophages and against mycelia by PMN. The strong resistance remaining after ablation of PMN by cytotoxic drugs demonstrates that macrophages can protect animals from high challenge doses of resting spores. When this first line of defense is overpowered with preincubated spores, normal mice can still resist infection, but neutropenic mice are overwhelmed. Thus, neutrophils form a second line of defense by killing mycelia. Natural resistance collapses only when both lines of defense are damaged, as seen after large doses of CA (Tables I and II) , which impair killing of conidia by macrophages and the mobilization of PMN around the fungus, or after combined immunosuppression with one dose of CA plus myelosuppression with HN2 (Table II) . Thus patients receiving organ transplants, who are at high risk of aspergillosis, receive both high doses of steroids and cytotoxic drugs and are often neutropenic (39) . Patients with chronic granulomatous disease are defective in oxidative killing so that their neutrophils would not be expected to kill mycelia nor their mononuclear cells to kill conidia. Old reviews of aspergillosis (1, 2) stem from a time when steroids were part of standard therapy of acute myelogenous leukemia. Lately, steroids are omitted but these patients continue to have serious problems with invasive aspergillosis. This clinical observation does not necessarily contradict our findings that mice immunosuppressed with myelotoxic drugs alone are quite resistant to a challenge with spores, because aplasia induced by treatment of leukemia lasts much longer than that induced in our mice. Aspergillosis is generally seen late in therapeutic aplasia and is not a complication of neutropenic episodes of short duration, an observation in agreement with our experimental findings. Furthermore, bacterial pneumonia often precedes invasive pulmonary aspergillosis (2), another factor that might affect resistance provided by resident pulmonary macrophages. The disease induced in mice after immunosuppression with a combined regimen of CA and HN2 or high doses of CA alone, which is characterized by invasive fungal growth in the lungs, penetration of pulmonary blood vessels, formation of infarcts and dissemination to the kidneys, brain, and liver, correspond well to the description of human disease (1, 2) .
These observations on the existence of alternative systems of cellular defense that can reinforce or replace the other has not been brought into focus before. Joint systems of humoral and cellular defense have been described in resistance to gram-negative bacteria and viruses (40) . Against fungi, however, humoral immunity seems to offer little if any resistance (41) , so that phagocytic cells are the main barrier against these organisms. It is intriguing that in the absence of effective antibody, the immune system can still call upon two lines of defense, and that these are two different kinds of phagocytic cells. It is also remarkable that each prong of this double system of cellular resistance is directed at only one of the two stages of the fungus: the macrophage against the spore and the granulocyte against the mycelium.
In contrast to aspergilli, more invasive fungi invade the host even in the presence of intact phagocytic defense systems. These fungi differ from aspergillus by their dimorphism that dispenses with mycelial growth in vivo. This conversion of the mycelial phase to the resistant tissue phase has been observed when spores or mycelia of Coccidioides immitis come under attack by macrophages (42) and PMN (43) . Control of infection with dimorphic fungi appears to require a specific cell-mediated immune response that is superfluous for monomorphic aspergilli, which are limited to mycelial growth in vivo.
